Published on in Vol 4, No 1 (2019): Jan-Dec

Immersive Virtual Reality in Health Care: Systematic Review of Technology and Disease States

Immersive Virtual Reality in Health Care: Systematic Review of Technology and Disease States

Immersive Virtual Reality in Health Care: Systematic Review of Technology and Disease States

Review

1School of Information Technology and Electrical Engineering, The University of Queensland, Brisbane, Australia

2Centre for Health Services Research, The University of Queensland, Brisbane, Australia

*all authors contributed equally

Corresponding Author:

Aaron J Snoswell, BEng

School of Information Technology and Electrical Engineering

The University of Queensland

Level 4 / General Purpose South Building (Building 78)

Brisbane, 4072

Australia

Phone: 61 422424060

Email: a.snoswell@uq.edu.au


Background: Immersive virtual reality (IVR) presents new possibilities for application in health care. Health care professionals can now immerse their patients in environments to achieve exposure to a specific scene or experience, evoke targeted emotional responses, inspire, or distract from an experience occurring in reality.

Objective: This review aimed to identify patient-focused applications for head-mounted IVR for acute treatment of health conditions and determine the technical specifications of the systems used.

Methods: A systematic review was conducted by searching medical and engineering peer-reviewed literature databases in 2018. The databases included PubMed, EMBASE, Cumulative Index to Nursing and Allied Health Literature, Association for Computing Machinery, Institute of Electrical and Electronics Engineers, Scopus, and Web of Science. Search terms relating to health and IVR were used. To be included, studies had to investigate the effectiveness of IVR for acute treatment of a specific health condition. IVR was defined as a head-mounted platform that provides virtual and auditory immersion for the participant and includes a minimum of 3 degrees of orientation tracking. Once identified, data were extracted from articles and aggregated in a narrative review format.

Results: A total of 58 studies were conducted in 19 countries. The studies reported IVR use for 5 main clinical areas: neurological and development (n=10), pain reduction through distraction (n=20), exposure therapy for phobias (n=9), psychological applications (n=14), and others (n=5). Studies were primarily feasibility studies exploring systems and general user acceptance (n=29) and efficacy studies testing clinical effect (n=28).

Conclusions: IVR has a promising future in health care, both in research and commercial realms. As many of the studies examined are still exploring the feasibility of IVR for acute treatment of health conditions, evidence for the effectiveness of IVR is still developing.

JMIR Biomed Eng 2019;4(1):e15025

doi:10.2196/15025

Keywords



Virtual reality (VR) has recently seen a resurgence of interest, both in the general public and academic communities. Technological improvements in processing, graphics, display, and 3D software have led to the release of several new commercially available VR systems since 2010. As a result, VR systems today cost one-sixtieth of the price, have better performance, and require less specialized hardware than systems from 20 years ago [1].

VR systems immerse the user in a virtual environment by completely replacing the visual environment and possibly aural sensation. The aim is to achieve a sense of presence such that the user perceives themselves as being part of the virtual environment. Key technical factors that help induce presence are accurate and stable tracking of the user’s head and possibly body motions, low-latency updating of the visual image provided to the user, a high display resolution, and a wide field of view.

Although commonly used for entertainment, VR is increasingly being used for so-called serious applications. Nonimmersive VR has a long history of use in health care; however, in this study, the more recent trends of immersive virtual reality (IVR) for health-related treatment applications are reviewed. IVR presents interesting possibilities for application in health care. Health care professionals can now immerse their patients in environments to achieve exposure to a specific scene or experience [2], evoke targeted emotional responses [3], inspire [4], or distract from an experience occurring in reality [5]. Relevant previous reviews have focused on specific clinical specialties such as mental health [6] or cognitive and motor rehabilitation [7,8]. This study aimed to summarize research across many clinical specialties. Findings are compared with those of related reviews in the Discussion section.

Terminology varies across different fields and from academia to public vocabulary. In this review, IVR is defined as a VR system that provides at least 3 degrees of freedom (DOF) of head orientation tracking (ie, roll, pitch, and yaw) and uses a head-mounted display (HMD) worn by the user. Traditionally, IVR may also include projection-based virtual environments (sometimes called CAVE systems). These systems were excluded to align this review with the recent trend of commercially available low-cost head-mounted devices. In addition to head orientation tracking, IVR systems may further provide head positional tracking or hand, controller, or body tracking in conjunction with various other sensory modalities such as haptic feedback.

Non-IVR systems that display a virtual environment to the user on a personal computer or mobile phone display without head tracking were excluded. Such systems have a long history of successful use in health care, most notably in psychology, with several reviews available [9-12]. Finally, this review did not focus on nontreatment applications of VR in health care such as for training.

The primary research question addressed by this review is as follows: what are the patient-focused applications for IVR in health research? This review examines the technical specifications of the systems being used and collates the health conditions being targeted.


Search Strategy

This review follows the methods described in a published protocol (PROSPERO 2018 CRD42018105512) [13]. Articles were included if they were published after 2010 when low cost IVR technology became commercially available. Only full-text journal articles available in English were included.

Search terms with appropriate amendments (dependent on medical subject headings) were used to search PubMed, EMBASE, Cumulative Index to Nursing and Allied Health Literature, Association for Computing Machinery, Institute of Electrical and Electronics Engineers, Scopus, and Web of Science for articles. ProQuest Global was additionally searched for theses. Search terms were (health OR rehabilitation OR telere* OR “digital health” OR ehealth OR “virtual care” OR telemedicine OR telehealth) and (“virtual environment” OR “artificial environment” OR “virtual reality”) not (surge*). Where possible, results were filtered to human-focused studies.

Article Selection

After duplicates were removed, titles and abstracts were screened for eligibility. The remaining articles were then read in full to confirm eligibility. Owing to the volume of articles returned, rehabilitation applications of IVR were excluded during the abstract and full-text review.

Studies were included if they related to any population receiving acute disease––specific treatment using IVR. Studies were excluded if they described training for health professionals in IVR (generally surgery education), non–earth-based applications (ie, focused, on space exploration), nonacute treatment applications such as rehabilitation, only described a system or hypothetical system without pilot or efficacy results, or were general well-being IVR systems for nondescript clinical purposes such as mood elevation or incentivizing exercise.

The primary search was conducted by one researcher (CS). Abstracts were reviewed by two researchers (CS and AS), with any disagreement discussed to reach consensus.

Data Extraction and Analysis

The data extracted included study type (efficacy or feasibility), IVR system, and condition and treatment purpose. Meta-analysis was not completed on the selected studies because of the large variation in identified studies.


Study Selection

Figure 1 shows the article selection process and lists the exclusion criteria. The study extraction and selected results are listed in Tables 1-5.

Figure 1. Article selection process. IVR: immersive virtual reality.
View this figure

A total of 58 studies were conducted in 19 countries. The studies reported IVR use for 5 main clinical areas: neurological and development (n=10), pain reduction through distraction (n=20), exposure therapy for phobias (n=9), other psychological applications (n=14), and other applications (n=5). Studies were categorized into 3 types: feasibility studies looking at the system and general user acceptance (n=29), efficacy studies testing clinical effect (n=28), and economic analysis (n=1).

What Are the Patient-Focused Applications for Immersive Virtual Reality in Health Research?

Neurological and Development

Ten articles reported that IVR was used for social attention training in children and adults with autism spectrum disorder [14-16]. Owing to the immersive nature of the environment, the individual’s attention can be directed in training scenarios [14]. Environments were designed to immerse patients in general social situations [14,17,18] or prepare them for specific social situation such as public bus rides [15]. IVR was used to achieve similar goals for children with intellectual development disabilities [19] and neurodevelopmental disorders [20].

IVR was also used to assist with the treatment of memory and cognitive functioning decline for individuals who had experienced a stroke or Alzheimer disease [21]. These IVR systems enabled individuals to practice undertaking everyday tasks in a simulated environment such as shopping for multiple items [21] or navigating a building structure [22].

Alternatively, IVR was used as a method of cognitive stimulation for patients in a hospital intensive care unit [23]. As these individuals were unable to leave their hospital environment, IVR created an opportunity for them to experience alternate environments to assist with cognitive stimulation [23]. See Table 1 for an overview.

Table 1. Included studies: neurological and development.
Author, year (country)Immersive virtual reality systemArticle typeCondition and treatment purposeNumber of participantsReported participant age (years)
Gerber et al, 2017 (Switzerland) [23]Oculus Developer Kit 2EfficacyCognitive stimulation for patients in the intensive care unit3720-85
Amaral et al, 2017 (Portugal) [14]Oculus Developer Kit 2FeasibilitySocial ability in autism spectrum disorder1715-26
Bernardes et al, 2015 (Portugal) [15]Not statedFeasibilitySocial ability in autism spectrum disorder532.2 (4)a
Fitzgerald et al, 2018 (Australia) [16]Oculus Commercial Version 1FeasibilityIncreased learning in autism spectrum disorder225-35
Gelsomini et al, 2016 (Italy) [19]Google CardboardFeasibilityLearn behavioral skills for individuals with intellectual development disabilities5Childrenb
Gelsomini et al 2016 (Italy) [20]Google CardboardFeasibilityFunctional improvement for individuals with neurodevelopment disorders106-10
Liu et al, 2018 (China) [17]HTC ViveFeasibilitySocial interaction in autism spectrum disorder45-7
Shahab et al, 2018 (Iran) [18]HTC ViveFeasibilityGame therapy for autism spectrum disorder14Childrenb
White et al, 2016 (Canada) [22]Oculus Developer Kit 2FeasibilityCognitive changes in Alzheimer disease174
Gamito et al, 2017 (Portugal) [21]eMagin Z800EfficacyAttention and memory after stroke2955 (14)a

aMean (SD).

bDirect quote from article, specific ages for participant/s not reported.

Pain Reduction Through Distraction

In this study, 20 articles reported that IVR was used for patients experiencing pain to distract them by providing alternate sensory input and to treat pain in specific populations with neck pain and phantom limb pain (Table 2).

Table 2. Included studies: pain reduction through distraction.
Author, year (country)Immersive virtual reality systemArticle typeCondition and treatment purposeNumber of participantsReported participant age (years)
Mosadeghi et al, 2016 (USA) [24]Samsung Gear VRFeasibilityHospitalized patients3049.1 (17)a
Delshad et al, 2018 (USA) [25]Samsung Gear VREconomic analysisHospital patientsNot applicableNot reported
Tashjian et al, 2017 (USA) [26]Samsung Gear VREfficacyHospitalized patients10054.5 (18)
Ambron et al, 2018 (USA) [27]Oculus Developer Kit 2FeasibilityPhantom limb pain2Middle aged to late-middle-agedb
Amin et al, 2017 (Canada) [5]Google Cardboard and Oculus Developer Kit 2EfficacyChronic pain3023-68
Birnie et al, 2018 (Canada) [28]Samsung Gear VRFeasibilityPediatric cancer178-18
Ebrahimi et al, 2017 (Iran) [29]Not reportedEfficacyDressing changes for burns patients6024-40
Faber et al, 2013 (USA) [30]Cybermind HiRes900EfficacyBurns patients368-57
Ford et al, 2018 (USA) [31]SunnypeakcFeasibilityBurns patients1030-69
Garrett et al, 2017 (Canada) [32]Oculus Developer Kit 2FeasibilityChronic pain831-71
Gold et al, 2018 (USA) [33]AppliedVR and Samsung Gear VR or Google MergeVREfficacyPhlebotomy14315.4 (3)a
Henriksen et al, 2017 (France) [34]Oculus Developer Kit 2FeasibilityPhantom limb pain345-60
Hoffman et al, 2014 (USA) [1]Oculus Commercial Version 1FeasibilitySkin stretching therapy for burns patients111
Jeffs et al, 2014 (USA) [35]Kaiser Optics SR80aEfficacyDressing changes for burns patients2810-17
Nielsen et al, 2017 (Denmark) [36]HTC ViveFeasibilityPhantom limb pain821-27
Osumi et al, 2017 (Japan) [37]Oculus Developer Kit 2FeasibilityPhantom limb pain843-64
Bahat et al, 2015 (Australia) [38]Vuzix Wrap 1200VRFeasibilityChronic pain and movement3240.6 (14)a
Bahat et al, 2018 (Australia) [39]Oculus Developer Kit 1EfficacyChronic pain and movement9038.5, 57.5d
Scapin et al, 2017 (Brazil) [40]Samsung Gear VRFeasibilityBurns patients28-9
Tanja-Dijkstra et al, 2014 (UK) [41]Vuzix iWear VR920EfficacyDental anxiety related to pain6933.1 (13)a

aMean (SD).

bDirect quote from article, specific ages for participant/s not reported.

cThese systems are low-cost phone-based head-mounted displays that are not widely commercially available.

dQuartile 1, quartile 3.

Distraction

IVR was used to provide patients with sensory information unrelated to their current situation or condition, the immersive nature of the virtual environments being a key factor in this application. Distraction through modified sensory input showed a reduction in pain sensations [5,24,26,32] and has been used to assist with painful procedures or exercises such as phlebotomy [28,33], dental appointments [41], dressing changes [29-31,35,40], and movement therapy for burns patients [1]. IVR has been used in both pediatric and adult populations for this purpose, in the hospital, clinic, and home settings [29-31,35,40].

Treatment

Studies were identified where IVR was used to replicate the treatment method Mirror Box Therapy, where patients use a mirror to create the illusion of an amputated limb still being present [36]. IVR represents a format in which amputated limbs can be simulated and used to complete gamified tasks [27,34,36,37]. IVR was also used to optimize the accuracy with which patients executed neck movement exercises to increase their range of motion and reduce their neck pain symptoms [38,39].

Exposure Therapy for Phobias

Overall, 9 articles reported that IVR has been harnessed to treat phobias, used as a method of either self-guided [42-44] or clinician-led [2,45,46] exposure therapy for patients (Table 3). Phobias included social phobia [2,42] (social anxiety disorder [SAD]), acrophobia [43,46] (fear of heights), agoraphobia [44,45] (fear of entering open or crowded places), aviophobia [47] (fear of flying), arachnophobia [3] (fear of spiders), and claustrophobia [48] (fear of confined spaces). Many of the IVR environments or activities were personalized for the specific patient, highlighting the benefit of using technology such as IVR for exposure therapy [2,3,49,42,44-45,46].

Table 3. Included studies: exposure therapy for phobias.
Author, year (country)Immersive virtual reality systemArticle typeCondition and treatment purposeNumber of participantsReported participant age (years)
Bouchard et al, 2017 (Canada) [2]eMagin Z800EfficacySocial phobia (SADa)5934.5 (12)b
Freeman et al, 2018 (UK) [49]HTC ViveEfficacyAcrophobia (fear of heights)10030-53
Hartanto et al, 2016 (Netherlands) [42]CustomFeasibilitySocial phobia (SADa)538-64
Hong et al, 2017 (Korea) [43]Samsung Gear VREfficacyAcrophobia (fear of heights)4823.2 (2)b
Malbos et al, 2013 (Australia) [44]Virtual Realities HMD42EfficacyAgoraphobia1824-72
Maples-Keller et al, 2017 (USA) [47]eMagin Z800EfficacyAviophobia (fear of flying)8921-67
Meyerbroeker et al, 2013 (Netherlands) [45]WorldViz Vizard 3.0EfficacyAgoraphobia5518-65
Shiban et al, 2015 (Germany) [3]eMagin Z800EfficacyArachnophobia4118-60
Shiban et al, 2016 (Germany) [48]eMagin Z800EfficacyClaustrophobia4818-65

aSocial anxiety disorder.

bMean (SD).

Other Psychological Applications

Overall, 14 articles reported other psychological application for IVR (Table 4), including self-management in depression [50,51], exposure therapy for posttraumatic stress disorder (PTSD) [52-54], reducing delusions and hallucinations [4,46,55,56], improving unhealthy eating habits [57-60], and reducing attention deficits in schizophrenia [61].

Table 4. Included studies: other psychological applications.
Author, year (country)Immersive virtual reality systemArticle typeCondition and treatment purposeNumber of participantsReported participant age (years)
Atherton et al, 2016 (UK) [55]nVisor SX111EfficacyPersecutory ideation in paranoid individuals2643.4 (16)a
Cai et al, 2017 (China) [50]Not reportedFeasibilitySelf-guided symptom management for individuals with depression1220-35
Cárdenas-López et al, 2014 (Mexico) [57]Neuro-VR 2.0FeasibilityIncreased weight loss after gastric band surgery for obesity332-44
Cárdenas-López et al, 2015 (Mexico) [58]Neuro-VR 2.0EfficacyIncreased weight loss in obese individuals24≥18 and ≤50
Dellazizzo et al, 2018 (Canada) [4]Samsung Gear VRFeasibilityReduction of verbal hallucination symptoms1Early 50sb
Dietrichkeit et al, 2018 (Germany) [56]Oculus Developer Kit 2FeasibilityRecall accuracy for individuals who experience delusions236-44
Freeman et al, 2016 (UK) [46]HTC ViveEfficacyReduced safety-seeking behavior in individuals with persecutory delusions3040.6 (14)a
Hussain et al, 2018 (USA) [51]Oculus Commercial Version 1FeasibilityIncrease in positivity generally and toward seeking help for depressed individuals1218-26
Keizer et al, 2016 (Netherlands) [59]Oculus Developer Kit 2EfficacyBody size distortion in anorexia nervosa3022 (4)a
La Paglia et al, 2016 (Italy) [61]Neuro-VR 2.0EfficacyAttention deficits in schizophrenia1529 (12)a
Marco et al, 2013 (Spain) [60]Not reportedFeasibilityEating disorders3415-40
McLay et al, 2017 (USA) [52]CustomEfficacyExposure therapy in posttraumatic stress disorder (PTSD)8833 (8)a
McLay et al, 2014 (USA) [53]CustomFeasibilitySymptoms reduction in PTSD2825-49
Reger et al, 2016 (USA) [54]eMagin Z800EfficacyExposure therapy for PTSD16229.5 (6)a

aMean (SD).

bDirect quote from article, specific ages for participant/s not reported.

Depression

Both depression-focused studies described self-administered VR therapy that could be used at home. In one case, a preprogrammed virtual avatar prompted individuals to share their experiences with depression with the aim of increasing self-help behaviors [51]. A second application featured integrated neurofeedback for self-management of symptoms at home through interaction with preprogrammed environments [41].

Posttraumatic Stress Disorder

IVR was used in two studies to improve the immersion of the experience for exposure therapy in PTSD treatments [52-54]. Exposure therapy using VR is well documented in the literature; however, only two studies were identified as immersive for this review.

Delusions and Hallucinations

IVR for persecutory delusions allowed patients to be immersed in social environments with progressively more avatars present, which enabled a safe situation to practice being in a social environment [46]. Another IVR experience used virtual immersive social environments to build self-confidence as a mechanism to combat paranoia and persecutory delusions [55]. IVR was also used to ameliorate delusions related to memory recall by using IVR to experience environments and practice recalling details accurately [56].

A case study examined using IVR as a mechanism for therapy for individuals experiencing verbal hallucinations. Using an avatar created in IVR, a therapist was able to virtually embody the persona of the verbal hallucination, allowing the patient a new mechanism of interactive therapy, which showed promising results [4].

Unhealthy Eating Habits

Overall, 4 papers described the results of studies using IVR to assist with acute unhealthy eating habits, including obesity, anorexia nervosa, and general eating disorders [57-60]. In all 4 studies, IVR was used to create a full-body illusion aimed at correcting inaccurate patient perceptions of themselves as a supplement to cognitive behavioral therapy [57-60].

Schizophrenia

Individuals living with schizophrenia received IVR-based cognitive behavioral therapy to undertake attention training tasks [61].

Other Applications

A total of 5 articles were identified where IVR was being used for patient-focused clinical application that did not specifically align with the other categories identified (Table 5). These articles demonstrated the use of IVR for vestibular conditions [62,63], tinnitus [64], multiple sclerosis [65], and balance control for fetal alcohol spectrum disorder (FASD) [66]. Of 3 studies, 2 reported using IVR to optimize patient execution of exercises to reduce vestibular conditions [62,63], including vestibular hypofunction and benign paroxysmal positional vertigo. IVR was also used to assist with specialist clinician-guided tinnitus treatment, in place of cognitive behavioral therapy [64]. Multiple sclerosis patients walked on a treadmill with sensors at their feet and used IVR to improve their gait while avoiding or stepping over virtual obstacles [65]. Children with FASD used IVR to enhance task-specific balance practice exercises, improving their overall balance control [66].

Table 5. Included studies: other applications.
Author, year (country)Immersive virtual reality systemArticle typeCondition and treatment purposeNumber of participantsReported participant age (years)
Malinvaud et al, 2016 (France) [64]Not reportedEfficacyReduced tinnitus symptoms14852.5 (13)a
Micarelli et al, 2017 (Italy) [62]RevelationbEfficacyVestibulo-ocular reflex gain in vestibular hypofunction5150.5 (9)a
Peruzzi et al, 2016 (Italy) [65]eMagin Z800FeasibilityGait improvement in multiple sclerosis patients834-60
Tabanfar et al, 2018 (Canada) [63]HooToobEfficacyEpley treatment for paroxysmal positional vertigo2026.4 (7)a
McCoy et al, 2015 (USA) [66]CustomFeasibilitySensorimotor balance control training for children with FASDc1111.4 (2)a

aMean (SD).

bThese systems are low-cost phone-based head-mounted displays that are not widely commercially available.

cFetal alcohol spectrum disorder.

What Are the Technical Specifications of These Systems?

Systems from 58 articles were categorized into 3 groups: commercially available integrated systems, commercially available systems that use a smartphone as a display device, and custom-designed systems that are not commercially available. Of 58 articles, 5 did not provide adequate information to identify the IVR system used, however, did provide adequate photos and use language to convince the authors that IVR was used in the study [15,29,50,60,64].

Where a system is reported to have 0 DOF of head tracking, the referenced studies incorporated an additional head tracking system to make the VR system immersive.

Some studies reported the use of IVR software that may support a variety of hardware devices. These studies were included when the authors were convinced that the reported software version supported IVR hardware as a display option. The software systems reported included NeuroVR version 2.0 (Milan, Italy) [61], WorldViz Vizard version 3.0 [45], and AppliedVR RelieVR [33]. In addition, one study reported the use of a modified HMD that included an eye tracking device [23]. Detailed technical specifications are listed in Tables 6-9.

Table 6. Commercially available, integrated immersive virtual reality systems.
ManufacturerSystemHead tracking DOFaDisplay resolutionHorizontal FOVb (degree)Number of studiesReferences
HTCVive62160×12001105Liu et al (2018) [17], Shahab et al (2017) [18], Nielsen et al (2017) [36], Freeman et al (2016) [49], and 2018 [46]
OculusRift Commercial Version 162160×12001103Hoffman et al (2014) [1], Fitzgerald et al (2018) [16], Hussain et al (2018) [51]
OculusRift Development Kit 261920×108010010Amin et al (2017) [5], White et al (2016) [22], Gerber et al (2017) [23], Amaral et al (2017),[14] Ambron et al (2018) [27], Garrett et al (2017) [32], Henriksen et al (2017) [34], Osumi et al (2017) [37], Dietrichkeit et al (2018) [56], Keizer et al (2016) [59]
OculusRift Development Kit 131280×8001101Bahat et al (2018) [39]
Kaiser OpticsSR80a01280×1024801Jeffs et al (2014) [35]
CybermindHiRes9000800×600approximately 501Faber et al (2013) [30]
eMaginZ80031600×600approximately 437Bouchard et al (2017) [2], Shiban et al (2015) [3], and (2016) [21], Gamito et al (2017) [47], Maples-Keller et al (2017) [48], Reger et al (2016) [54], Peruzzi et al 2016 [65]
Virtual RealitiesVR128001280×1024601Atherton et al (2016) [55]
Virtual RealitiesHMD423800×600421Malbos et al (2013) [44]
nVisorSX11101280×10241021Atherton et al (2016) [55]
VuzixWrap 1200VR31280×720351Bahat et al (2015) [38]
VuzixiWear VR92031280×480321Tanja-Dijkstra et al (2014) [41]

aDOF: degrees of freedom.

bFOV: field of view.

Table 7. Commercially available, smartphone-based immersive virtual reality systems.
ManufacturerSystemMobile deviceHead tracking DOFaDisplay resolutionNumber of studiesReferences
SamsungGear VRSamsung Note 432560×14402Scapin et al (2016) [24], Mosadeghi et al (2016) [40]
SamsungGear VRSamsung Galaxy S732560×14401Tashjian et al (2017) [26]
SamsungGear VRSamsung Galaxy S632560×14403Birnie et al (2018) [28], Gold et al (2018) [33], Hong (2017) [43]
GoogleMergeVRGoogle Pixel (version not reported)3b1Gold et al (2018) [33]
GoogleCardboardSamsung Galaxy Note 432560×14401Amin et al (2017) [5]
GoogleCardboardApple iPod Touch (fifth Generation)31136×6401Ford et al (2018) [31]
GoogleCardboardNot reported3b2Gelsomini et al (2016a) [19] and (2016b) [20]
Not statedSunnypeakApple iPod (version unstated)3b1Ford et al (2018) [31]
Not statedHooTooApple iPhone 631334×7501Tabanfar et al (2018) [63]
Not statedRevelationNokia Lumia 93031920×10801Micarelli et al (2017) [62]

aDOF: degrees of freedom.

bUnknown as mobile device was not reported.

Table 8. Custom immersive virtual reality systems.
SystemHead tracking DOFaDisplay resolutionHorizontal FOVb (degree)Number of studiesReferences
MemphisNot reportedNot reportedNot reported1Hartanto et al (2015) [42]
STABELcNot reportedNot reportedNot reported1McCoy et al (2015) [66]
VRGETdNot reportedNot reportedNot reported2McLay et al (2014) [52] and (2017) [53]

aDOF: degrees of freedom.

bFOV: field of view.

cSTABEL: Sensorimotor Training to Affect Balance, Engagement and Learning.

dVRGET: Virtual Reality Graded Exposure Therapy.

Table 9. Immersive virtual reality software frameworks.
ManufacturerSystemNumber of studiesReferences
Neuro-VRNeuro-VR 2.03Cardenas-Lopez et al (2014) [57] and (2015) [58], La Paglia (2016) [61]
WorldVizVizard 3.01Meyerbroeker et al (2013) [45]
AppliedVRRelieVR1Gold et al (2018) [33]

Principal Findings

This review identified 58 studies from 19 countries that used IVR for acute treatment of conditions. The included studies featured participants ranging in age from 5 to 74 years, with one acceptability study reporting a significant age difference between participants willing to use IVR (younger participants) and those unwilling to use IVR (older participants) [24]. The conditions treated in the included studies were broadly in 5 categories: neurological and neurodevelopment, pain, phobias, psychological applications, and miscellaneous. All the studies used IVR to immerse patients into a virtual environment, but the purposes were different; examples including experience of an environment, exposure therapy, and assistance with accuracy of movement or distraction. The IVR applications presented in the reviewed articles were at different stages of maturity. Approximately half of the reviewed articles tested the feasibility of treatment with IVR, whereas others that were slightly more mature tested the efficacy of IVR compared with conventional treatment methods. This suggests that although nonimmersive VR has a long history of use in health treatment [67], IVR as a tool in treatment and management of health conditions is still a developing area.

A benefit of IVR systems is that the simulated environment can be easily tailored to the individual patient, such as the clinician controlling a virtual embodiment of an avatar that is relevant to the patient’s condition, or designing a specific, patient-relevant environment [46,51]; however, such applications require careful system design that takes the clinician’s technical abilities into account. Future generations of commercially available IVR systems will likely have an increasing focus on social and multiuser interactions, further enabling interactive treatment methodologies that are already being employed [14,15,44,45].

Future Directions and Implications for Practice

The data indicate that IVR systems are sometimes extended with other sensors and input modalities such as integrating eye tracking [23] or brain-computer interfaces [14]. Although useful in some health settings, such extensions of IVR may not become commonplace in commercial systems designed for general consumers. However, the budding applications of IVR in health care may inform the future development of commercial IVR technology, including considerations such as water resistance for use in water-based therapy regimes or high-moisture environments [68,69]. Some studies also described the use of weight-assisting arms to support an HMD when the patient may not be able to support the weight of the device themselves [1].

It appears that IVR has a promising future in health care, in research and commercial realms. As many of the studies examined are exploratory, the feasibility of IVR for acute treatment of conditions and the evidence for the effectiveness of IVR is still developing. The studies that did examine efficacy demonstrated preliminary evidence that IVR is either as effective as or more effective than their selected conventional therapy. A majority of the studies had low participant numbers and did not extend their analysis to undertake statistical significance testing of a hypothesis. Future research into the effectiveness of IVR could incorporate more rigorous statistical methods to examine effectiveness.

In the studies, it was reviewed here that commercially available IVR systems are not commonly being used for in-home or self-treatment regimes. This highlights a potential application area that could be investigated in the future: the use of IVR in a telehealth or remote health setting.

The early state of IVR technology adoption highlights another area for future work: the development of policy and procedural guidelines for patient safety and security when interacting with IVR technology. For example, such procedures may consider the need for antibacterial design or treatment of face-touching components for sharing of IVR HMDs and calibration of IVR technology to the individual patient’s sensory ability to prevent or reduce simulation sickness. Policies should also consider and address patient data protection issues, and provide adequate guidance on privacy, specifically for biometric or similar data collected when interacting with IVR systems.

Implications for Research

From a research quality perspective, this review highlighted that many studies did not provide adequate detailed technical information about the IVR system being used—this aligns with findings of poor reporting quality from previous reviews [6]. Details such as specific software and hardware versions were not routinely reported in adequate detail for technical systems to be reproducible. Especially in the case of custom IVR systems, it is important for such details to be reported thoroughly to aid research quality, peer-review, evaluation, and reproducibility. This is an area where future studies could improve their reporting. For example, including a photo or diagram of a patient interacting with the IVR system provides a rich source of information for the reader, while adding minimal text to a research manuscript.

Limitations

Owing to the volume of studies, this review had to be limited to acute treatment applications of IVR. IVR has also appeared in health literature as a training tool for health professionals, especially for surgical applications and in rehabilitation to increase compliance with exercise regimes and improve the accuracy of rehabilitation task completion. Any of the several existing reviews can be referred to for more information about the use of IVR in these areas.

Conclusions

Some studies indicate that simulation sickness is still a limiting factor for application of IVR systems in health care [26,70,71]. This is an ongoing area of research in the broader IVR community [71], and future improvements to IVR system design will likely increase the compatibility of IVR technology with the general populace. In the interim, this finding highlights the need for best practice guidelines for IVR system deployment and development. Furthermore, IVR systems are not suitable for all populations—a consideration that is important for health applications. However, IVR technology can be adapted to suit the needs of specific populations such as blind or low-vision patients [72,73]. The emergence of a technical contracting business that specializes in IVR for health applications is a promising step in this direction. To this end, there is a need for close integration of technical and clinical team members to maximize the efficacy of any new or proposed system.

Conflicts of Interest

None declared.

References

  1. Hoffman HG, Meyer 3rd WJ, Ramirez M, Roberts L, Seibel EJ, Atzori B, et al. Feasibility of articulated arm mounted Oculus Rift virtual Reality goggles for adjunctive pain control during occupational therapy in pediatric burn patients. Cyberpsychol Behav Soc Netw 2014 Jun;17(6):397-401 [FREE Full text] [CrossRef] [Medline]
  2. Bouchard S, Dumoulin S, Robillard G, Guitard T, Klinger E, Forget H, et al. Virtual reality compared with exposure in the treatment of social anxiety disorder: a three-arm randomised controlled trial. Br J Psychiatry 2017 Apr;210(4):276-283 [FREE Full text] [CrossRef] [Medline]
  3. Shiban Y, Brütting J, Pauli P, Mühlberger A. Fear reactivation prior to exposure therapy: does it facilitate the effects of VR exposure in a randomized clinical sample? J Behav Ther Exp Psychiatry 2015 Mar;46:133-140. [CrossRef] [Medline]
  4. Dellazizzo L, du Sert OP, Potvin S, Breton R, Pelletier J, Renaud P, et al. Avatar therapy for persistent auditory verbal hallucinations: a case report of a peer research assistant on his path toward recovery. Psychosis 2018 Aug 3;10(3):213-219. [CrossRef]
  5. Amin AM, Tong X, Gromala D, Shaw CD. Cardboard Mobile Virtual Reality as an Approach for Pain Distraction in Clinical Settings: Comparison, Exploration and Evaluation with Oculus Rift. In: Proceedings of the 2017 CHI Conference Extended Abstracts on Human Factors in Computing Systems. 2017 Presented at: CHI EA'17; May 6-11, 2017; Denver, Colorado, USA p. 2345-2351   URL: https://dl.acm.org/citation.cfm?doid=3027063.3053234 [CrossRef]
  6. Jerdan SW, Grindle M, van Woerden HC, Boulos MN. Head-mounted virtual reality and mental health: critical review of current research. JMIR Serious Games 2018 Jul 6;6(3):e14 [FREE Full text] [CrossRef] [Medline]
  7. Tieri G, Morone G, Paolucci S, Iosa M. Virtual reality in cognitive and motor rehabilitation: facts, fiction and fallacies. Expert Rev Med Devices 2018 Feb;15(2):107-117 [FREE Full text] [CrossRef] [Medline]
  8. Laver KE, Lange B, George S, Deutsch JE, Saposnik G, Crotty M. Virtual reality for stroke rehabilitation. Cochrane Database Syst Rev 2017 Nov 20;11:CD008349 [FREE Full text] [CrossRef] [Medline]
  9. Krijn M, Emmelkamp PM, Olafsson RP, Bouwman M, van Gerwen LJ, Spinhoven P, et al. Fear of flying treatment methods: virtual reality exposure vs cognitive behavioral therapy. Aviat Space Environ Med 2007 Feb;78(2):121-128. [Medline]
  10. Riva G. Virtual reality in psychotherapy: review. Cyberpsychol Behav 2005 Jun;8(3):220-30; discussion 231 [FREE Full text] [CrossRef] [Medline]
  11. Ricciardi F, de Paolis LT. A comprehensive review of serious games in health professions. Int J Comput Games Technol 2014 Jan;2014:1-11 [FREE Full text] [CrossRef]
  12. Bartolomé NA, Zorrilla AM, Zapirain BG. Can Game-Based Therapies Be Trusted? Is Game-Based Education Effective? A Systematic Review of the Serious Games for Health and Education. In: Proceedings of the 16th International Conference on Computer Games. 2011 Presented at: CGAMES'11; July 27-30, 2011; Louisville, KY, USA p. 275-282   URL: https://ieeexplore.ieee.org/abstract/document/6000353 [CrossRef]
  13. Snoswell CL, Snoswell AJ. University of York. 2018. The Use of Immersive and Portable Virtual Reality in Patient-Focused Healthcare   URL: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42018105512 [accessed 2018-11-08]
  14. Amaral CP, Simões MA, Mouga S, Andrade J, Castelo-Branco M. A novel Brain Computer Interface for classification of social joint attention in autism and comparison of 3 experimental setups: a feasibility study. J Neurosci Methods 2017 Oct 1;290:105-115 [FREE Full text] [CrossRef] [Medline]
  15. Bernardes M, Barros F, Simoes M, Castelo-Branco M. A Serious Game With Virtual Reality for Travel Training With Autism Spectrum Disorder. In: Proceedings of the International Conference on Virtual Rehabilitation. 2015 Presented at: ICVR'15; June 9-12, 2015; Valencia, Spain p. 127-128   URL: https://ieeexplore.ieee.org/abstract/document/7358609/authors#authors [CrossRef]
  16. Fitzgerald E, Yap HK, Ashton C, Moore DW, Furlonger B, Anderson A, et al. Comparing the effectiveness of virtual reality and video modelling as an intervention strategy for individuals with autism spectrum disorder: brief report. Dev Neurorehabil 2018 Apr 5;21(3):197-201. [CrossRef] [Medline]
  17. Liu S, Xi Y, Wang H. The Utility of the Virtual Reality in Autistic Disorder Treatment. In: Proceedings of the International Conference on Universal Access in Human-Computer Interaction. 2018 Presented at: UAHCI'18; July 15-20, 2018; Las Vegas, NV, USA p. 551-559   URL: https://link.springer.com/chapter/10.1007%2F978-3-319-92049-8_40 [CrossRef]
  18. Shahab M, Taheri A, Hosseini SR, Mokhtari M, Meghdari A, Alemi M, et al. Social Virtual Reality Robot (V2R): A Novel Concept for Education and Rehabilitation of Children with Autism. In: Proceedings of the 5th RSI International Conference on Robotics and Mechatronics. 2017 Presented at: ICRoM'17; October 25-27, 2017; Tehran, Iran p. 82-87   URL: https://ieeexplore.ieee.org/abstract/document/8466148 [CrossRef]
  19. Gelsomini M, Garzotto F, Montesano D, Occhiuto D. Wildcard: a wearable virtual reality storytelling tool for children with intellectual developmental disability. Conf Proc IEEE Eng Med Biol Soc 2016 Aug;2016:5188-5191. [CrossRef] [Medline]
  20. Gelsomini M. An Affordable Virtual Reality Learning Framework for Children With Neurodevelopmental Disorder. In: Proceedings of the 18th International ACM SIGACCESS Conference on Computers and Accessibility. 2016 Presented at: ASSETS'16; October 23-26, 2016; Reno, Nevada, USA p. 343-344   URL: https://dl.acm.org/citation.cfm?id=2982143 [CrossRef]
  21. Gamito P, Oliveira J, Coelho C, Morais D, Lopes P, Pacheco J, et al. Cognitive training on stroke patients via virtual reality-based serious games. Disabil Rehabil 2017 Feb;39(4):385-388. [CrossRef] [Medline]
  22. White PJ, Moussavi Z. Neurocognitive treatment for a patient with Alzheimer's disease using a virtual reality navigational environment. J Exp Neurosci 2016;10:129-135 [FREE Full text] [CrossRef] [Medline]
  23. Gerber SM, Jeitziner MM, Wyss P, Chesham A, Urwyler P, Müri RM, et al. Visuo-acoustic stimulation that helps you to relax: a virtual reality setup for patients in the intensive care unit. Sci Rep 2017 Oct 16;7(1):13228 [FREE Full text] [CrossRef] [Medline]
  24. Mosadeghi S, Reid MW, Martinez B, Rosen BT, Spiegel BM. Feasibility of an immersive virtual reality intervention for hospitalized patients: an observational cohort study. JMIR Ment Health 2016 Jun 27;3(2):e28 [FREE Full text] [CrossRef] [Medline]
  25. Delshad SD, Almario CV, Fuller G, Luong D, Spiegel BM. Economic analysis of implementing virtual reality therapy for pain among hospitalized patients. NPJ Digit Med 2018;1:22 [FREE Full text] [CrossRef] [Medline]
  26. Tashjian VC, Mosadeghi S, Howard AR, Lopez M, Dupuy T, Reid M, et al. Virtual reality for management of pain in hospitalized patients: results of a controlled trial. JMIR Ment Health 2017 Mar 29;4(1):e9 [FREE Full text] [CrossRef] [Medline]
  27. Ambron E, Miller A, Kuchenbecker KJ, Buxbaum LJ, Coslett HB. Immersive low-cost virtual reality treatment for phantom limb pain: evidence from two cases. Front Neurol 2018;9:67 [FREE Full text] [CrossRef] [Medline]
  28. Birnie KA, Kulandaivelu Y, Jibb L, Hroch P, Positano K, Robertson S, et al. Usability testing of an interactive virtual reality distraction intervention to reduce procedural pain in children and adolescents with cancer [Formula: see text]. J Pediatr Oncol Nurs 2018;35(6):406-416 [FREE Full text] [CrossRef] [Medline]
  29. Ebrahimi H, Namdar H, Ghahramanpour M, Ghafourifard M, Musavi S. Effect of virtual reality method and multimedia system on burn patients' pain during dressing. J Clin Anal Med 2017;8:485-489 [FREE Full text] [CrossRef]
  30. Faber AW, Patterson DR, Bremer M. Repeated use of immersive virtual reality therapy to control pain during wound dressing changes in pediatric and adult burn patients. J Burn Care Res 2013;34(5):563-568 [FREE Full text] [CrossRef] [Medline]
  31. Ford CG, Manegold EM, Randall CL, Aballay AM, Duncan CL. Assessing the feasibility of implementing low-cost virtual reality therapy during routine burn care. Burns 2018 Jun;44(4):886-895 [FREE Full text] [CrossRef] [Medline]
  32. Garrett B, Taverner T, McDade P. Virtual reality as an adjunct home therapy in chronic pain management: an exploratory study. JMIR Med Inform 2017 May 11;5(2):e11 [FREE Full text] [CrossRef] [Medline]
  33. Gold JI, Mahrer NE. Is virtual reality ready for prime time in the medical space? A randomized control trial of pediatric virtual reality for acute procedural pain management. J Pediatr Psychol 2018 Apr 1;43(3):266-275. [CrossRef] [Medline]
  34. Henriksen B, Nielsen R, Kraus M, Geng B. A Virtual Reality System for Treatment of Phantom Limb Pain Using Game Training and Tactile Feedback. In: Proceedings of the Virtual Reality International Conference - Laval Virtual 2017. 2017 Presented at: VRIC'17; March 22-24, 2017; Laval, France   URL: https://dl.acm.org/citation.cfm?id=3110306 [CrossRef]
  35. Jeffs D, Dorman D, Brown S, Files A, Graves T, Kirk E, et al. Effect of virtual reality on adolescent pain during burn wound care. J Burn Care Res 2014;35(5):395-408 [FREE Full text] [CrossRef] [Medline]
  36. Nielsen R, Henriksen B, Kraus M, Geng B. Comparison of Body Positions in Virtual Reality Mirror Box Therapy for Treatment of Phantom Limb Pain in Lower Limb Amputees. In: Proceedings of the Virtual Reality International Conference - Laval Virtual. 2017 Presented at: VRIC'17; March 22-24, 2017; Laval, France   URL: https://dl.acm.org/citation.cfm?id=3110307 [CrossRef]
  37. Osumi M, Ichinose A, Sumitani M, Wake N, Sano Y, Yozu A, et al. Restoring movement representation and alleviating phantom limb pain through short-term neurorehabilitation with a virtual reality system. Eur J Pain 2017 Jan;21(1):140-147 [FREE Full text] [CrossRef] [Medline]
  38. Bahat HS, Takasaki H, Chen X, Bet-Or Y, Treleaven J. Cervical kinematic training with and without interactive VR training for chronic neck pain - a randomized clinical trial. Man Ther 2015 Feb;20(1):68-78 [FREE Full text] [CrossRef] [Medline]
  39. Bahat HS, Croft K, Carter C, Hoddinott A, Sprecher E, Treleaven J. Remote kinematic training for patients with chronic neck pain: a randomised controlled trial. Eur Spine J 2018 Jun;27(6):1309-1323 [FREE Full text] [CrossRef] [Medline]
  40. Scapin SQ, Echevarría-Guanilo ME, Fuculo PR, Martins JC, Barbosa MD, Pereima MJ. Use of virtual reality for treating burned children: case reports. Rev Bras Enferm 2017;70(6):1291-1295 [FREE Full text] [CrossRef] [Medline]
  41. Tanja-Dijkstra K, Pahl S, White MP, Andrade J, Qian C, Bruce M, et al. Improving dental experiences by using virtual reality distraction: a simulation study. PLoS One 2014;9(3):e91276 [FREE Full text] [CrossRef] [Medline]
  42. Hartanto D, Brinkman WP, Kampmann IL, Morina N, Emmelkamp PG, Neerincx MA. Home-Based Virtual Reality Exposure Therapy with Virtual Health Agent Support. In: Proceedings of the International Symposium on Pervasive Computing Paradigms for Mental Health. 2015 Presented at: MindCare'15; September 24-25, 2015; Milan, Italy p. 85-98   URL: https://link.springer.com/content/pdf/10.1007/978-3-319-32270-4.pdf#page=92 [CrossRef]
  43. Hong YJ, Kim HE, Jung YH, Kyeong S, Kim J. Usefulness of the mobile virtual reality self-training for overcoming a fear of heights. Cyberpsychol Behav Soc Netw 2017 Dec;20(12):753-761 [FREE Full text] [CrossRef] [Medline]
  44. Malbos E, Rapee RM, Kavakli M. A controlled study of agoraphobia and the independent effect of virtual reality exposure therapy. Aust N Z J Psychiatry 2013 Feb;47(2):160-168. [CrossRef] [Medline]
  45. Meyerbroeker K, Morina N, Kerkhof GA, Emmelkamp P. Virtual reality exposure therapy does not provide any additional value in agoraphobic patients: a randomized controlled trial. Psychother Psychosom 2013;82(3):170-176 [FREE Full text] [CrossRef] [Medline]
  46. Freeman D, Bradley J, Antley A, Bourke E, DeWeever N, Evans N, et al. Virtual reality in the treatment of persecutory delusions: randomised controlled experimental study testing how to reduce delusional conviction. Br J Psychiatry 2016 Jul;209(1):62-67 [FREE Full text] [CrossRef] [Medline]
  47. Maples-Keller JL, Price M, Jovanovic T, Norrholm SD, Odenat L, Post L, et al. Targeting memory reconsolidation to prevent the return of fear in patients with fear of flying. Depress Anxiety 2017 Jul;34(7):610-620 [FREE Full text] [CrossRef] [Medline]
  48. Shiban Y, Peperkorn H, Alpers GW, Pauli P, Mühlberger A. Influence of perceptual cues and conceptual information on the activation and reduction of claustrophobic fear. J Behav Ther Exp Psychiatry 2016 Jun;51:19-26. [CrossRef] [Medline]
  49. Freeman D, Haselton P, Freeman J, Spanlang B, Kishore S, Albery E, et al. Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial. Lancet Psychiatry 2018 Aug;5(8):625-632 [FREE Full text] [CrossRef] [Medline]
  50. Cai H, Wang Z, Zhang Y, Chen Y, Bin H. A Virtual-Reality Based Neurofeedback Game Framework for Depression Rehabilitation using Pervasive Three-Electrode EEG Collector. In: Proceedings of the 12th Chinese Conference on Computer Supported Cooperative Work and Social Computing. 2017 Presented at: ChineseCSCW'17; September 22-23, 2017; Chongqing, China p. 173-176   URL: https://dl.acm.org/citation.cfm?id=3127433 [CrossRef]
  51. Hussain SA, Park T, Yildirim I, Xiang Z, Abbas F. Virtual-Reality Videos to Relieve Depression. In: Proceedings of the International Conference on Virtual, Augmented and Mixed Reality. 2018 Presented at: VAMR'18; July 15-20, 2018; Las Vegas, FL, USA p. 77-85   URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929408/ [CrossRef]
  52. McLay RN, Baird A, Webb-Murphy J, Deal W, Tran L, Anson H, et al. A randomized, head-to-head study of virtual reality exposure therapy for posttraumatic stress disorder. Cyberpsychol Behav Soc Netw 2017 Apr;20(4):218-224 [FREE Full text] [CrossRef] [Medline]
  53. McLay R, Ram V, Murphy J, Spira J, Wood DP, Wiederhold MD, et al. Effect of virtual reality PTSD treatment on mood and neurocognitive outcomes. Cyberpsychol Behav Soc Netw 2014 Jul;17(7):439-446 [FREE Full text] [CrossRef] [Medline]
  54. Reger GM, Koenen-Woods P, Zetocha K, Smolenski DJ, Holloway KM, Rothbaum BO, et al. Randomized controlled trial of prolonged exposure using imaginal exposure vs virtual reality exposure in active duty soldiers with deployment-related posttraumatic stress disorder (PTSD). J Consult Clin Psychol 2016 Nov;84(11):946-959 [FREE Full text] [CrossRef] [Medline]
  55. Atherton S, Antley A, Evans N, Cernis E, Lister R, Dunn G, et al. Self-confidence and paranoia: an experimental study using an immersive virtual reality social situation. Behav Cogn Psychother 2016 Jan;44(1):56-64 [FREE Full text] [CrossRef] [Medline]
  56. Dietrichkeit M, Flint K, Krieger E, Grzella K, Nagel M, Moritz S. Two case studies from a virtual reality intervention for delusions: feasibility and preliminary evidence. Cogn Behav Ther 2018 Aug 1;11:e10 [FREE Full text] [CrossRef]
  57. Cárdenas-López G, Torres-Villalobos G, Martinez P, Carreño V, Duran X, Dakanalis A, et al. Virtual reality for improving body image disorders and weight loss after gastric band surgery: a case series. Stud Health Technol Inform 2014;196:43-47 [FREE Full text] [CrossRef] [Medline]
  58. Cárdenas-López G, Martinez P, Riva G, Duran-Baca X, Gonzalo T. Virtual Reality Environments as Auxiliaries in the Treatment of Obesity. In: Proceedings of the 2015 Virtual Reality International Conference. 2015 Presented at: VRIC'15; April 8-10, 2015; Laval, France   URL: https://dl.acm.org/citation.cfm?id=2806175 [CrossRef]
  59. Keizer A, van Elburg A, Helms R, Dijkerman HC. A virtual reality full body illusion improves body image disturbance in anorexia nervosa. PLoS One 2016;11(10):e0163921 [FREE Full text] [CrossRef] [Medline]
  60. Marco JH, Perpiñá C, Botella C. Effectiveness of cognitive behavioral therapy supported by virtual reality in the treatment of body image in eating disorders: one year follow-up. Psychiatry Res 2013 Oct 30;209(3):619-625 [FREE Full text] [CrossRef] [Medline]
  61. la Paglia F, la Cascia C, Rizzo R, Sanna M, Sideli L, Francomano A, et al. Virtual reality environments to rehabilitation attention deficits in schizophrenic patients. Ann Rev Psychother Telemed 2016;14:143-148 [FREE Full text]
  62. Micarelli A, Viziano A, Augimeri I, Micarelli D, Alessandrini M. Three-dimensional head-mounted gaming task procedure maximizes effects of vestibular rehabilitation in unilateral vestibular hypofunction: a randomized controlled pilot trial. Int J Rehabil Res 2017 Dec;40(4):325-332. [CrossRef] [Medline]
  63. Tabanfar R, Chan HH, Lin V, Le T, Irish JC. Development and face validation of a Virtual reality Epley maneuver system (VREMS) for home Epley treatment of benign paroxysmal positional vertigo: a randomized, controlled trial. Am J Otolaryngol 2018;39(2):184-191 [FREE Full text] [CrossRef] [Medline]
  64. Malinvaud D, Londero A, Niarra R, Peignard P, Warusfel O, Viaud-Delmon I, et al. Auditory and visual 3D virtual reality therapy as a new treatment for chronic subjective tinnitus: results of a randomized controlled trial. Hear Res 2016 Mar;333:127-135 [FREE Full text] [CrossRef] [Medline]
  65. Peruzzi A, Cereatti A, Croce UD, Mirelman A. Effects of a virtual reality and treadmill training on gait of subjects with multiple sclerosis: a pilot study. Mult Scler Relat Disord 2016 Jan;5:91-96 [FREE Full text] [CrossRef] [Medline]
  66. McCoy SW, Jirikowic T, Price R, Ciol MA, Hsu L, Dellon B, et al. Virtual sensorimotor balance training for children with fetal alcohol spectrum disorders: feasibility study. Phys Ther 2015 Nov;95(11):1569-1581 [FREE Full text] [CrossRef] [Medline]
  67. Rose T, Nam CS, Chen KB. Immersion of virtual reality for rehabilitation - review. Appl Ergon 2018 May;69:153-161 [FREE Full text] [CrossRef] [Medline]
  68. Quarles J. Shark Punch: A Virtual Reality Game for Aquatic Rehabilitation. In: Proceedings of the Conference on Virtual Reality. 2015 Presented at: VR'15; March 23-27, 2015; Arles, France p. 265-266   URL: https://ieeexplore.ieee.org/abstract/document/7223397 [CrossRef]
  69. Lv Z. Bringing Immersive Enjoyment to Hyperbaric Oxygen Chamber Users Using Virtual Reality Glasses. In: Proceedings of the 3rd 2015 Workshop on ICTs for improving Patients Rehabilitation Research Techniques. 2015 Oct 01 Presented at: REHAB'15; October 1-2, 2015; Lisbon, Portugal p. 156-159   URL: https://dl.acm.org/citation.cfm?id=2838982 [CrossRef]
  70. Hartnagel D, Taffou M, Sandor PM. Effects of Short Exposure to a Simulation in a Head-Mounted Device and the Individual Differences Issue. In: Proceedings of the International Conference on Human-Computer Interaction. 2017 Presented at: HCI'17; July 9-14, 2017; Vancouver, Canada p. 9-16   URL: https://link.springer.com/chapter/10.1007/978-3-319-58753-0_2#aboutcontent [CrossRef]
  71. Nalivaiko E, Davis SL, Blackmore KL, Vakulin A, Nesbitt KV. Cybersickness provoked by head-mounted display affects cutaneous vascular tone, heart rate and reaction time. Physiol Behav 2015 Nov 1;151:583-590 [FREE Full text] [CrossRef] [Medline]
  72. Lahav O, Gedalevitz H, Battersby S, Brown D, Evett L, Merritt P. Virtual environment navigation with look-around mode to explore new real spaces by people who are blind. Disabil Rehabil 2018 May;40(9):1072-1084 [FREE Full text] [CrossRef] [Medline]
  73. Lahav O, Schloerb DW, Srinivasan MA. Rehabilitation program integrating virtual environment to improve orientation and mobility skills for people who are blind. Comput Educ 2015 Jan 1;80:1-14 [FREE Full text] [CrossRef] [Medline]


DOF: degrees of freedom
FASD: Fetal Alcohol Spectrum Disorder
HMD: head-mounted display
IVR: immersive virtual reality
PTSD: posttraumatic stress disorder
SAD: social anxiety disorder
VR: virtual reality


Edited by G Eysenbach; submitted 15.06.19; peer-reviewed by J Salisbury, A Aminbeidokhti, T Muto; comments to author 24.07.19; revised version received 13.08.19; accepted 18.08.19; published 26.09.19

Copyright

©Aaron J Snoswell, Centaine L Snoswell. Originally published in JMIR Biomedical Engineering (http://biomedeng.jmir.org), 26.09.2019

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Biomedical Engineering, is properly cited. The complete bibliographic information, a link to the original publication on http://biomedeng.jmir.org/, as well as this copyright and license information must be included.